NeXtGen Biologics
Growth Stage
Patented, FDA Cleared, Novel Wound-Care Technology. New Skin In The Game!
Overview
Raised: $241,610
Total Commitments ($USD)
Platform
Republic
Start Date
09/01/2022
Close Date
02/28/2023
Min. Goal
$25,000
Max. Goal
$5,000,000
Min. Investment
$250
Security Type
SAFE
Series
Series A
SEC Filing Type
RegCF
Valuation Cap
$40,000,000
Discount
0%
Rolling Commitments ($USD)
Status
Funded
Reporting Date
03/04/2023
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$1,350
# of Investors
346
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2014
Industry
Healthcare & Pharmaceuticals
Tech Sector
Biotech
Distribution Model
B2C
Margin
High
Capital Intensity
High
NeXtGen Biologics, with a valuation of $40 million, is raising funds on Republic. The company has developed a patented and FDA-cleared wound-care technology involving the extracellular matrix (ECM). The technology captures the regenerative power of the axolotl and has potential applications in general surgery, wounds and burns, plastic surgery, cardiovascular diseases, ophthalmology, and gastrointestinal diseases. The first product of NeXtGen Biologics, NEOMATRIX, is the first ECM product derived from the axolotl and available to physicians and patients. Jonelle Toothman founded NeXtGen Biologics in April 2014. The current crowdfunding campaign has a minimum target of $25,000 and a maximum target of $5 million. The campaign proceeds will be used for the soft and full-scale launch of NEOMATRIX.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$0 |
$0 |
|
COGS |
$0 |
$0 |
|
Tax |
$-110,221 |
$51,772 |
| ||
| ||
|
Net Income |
$-2,007,144 |
$-790,983 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$337,233 |
$516,897 |
|
Accounts Receivable |
$0 |
$0 |
|
Total Assets |
$1,547,848 |
$2,069,171 |
|
Short-Term Debt |
$9,761,500 |
$9,110,917 |
|
Long-Term Debt |
$0 |
$155,400 |
|
Total Liabilities |
$9,761,500 |
$9,266,317 |
Financials as of: 09/01/2022
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Ratings 
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.